BRIEF-FDA Advances Policies To Bring More Predictability And Certainty To Drug Development Process

April 13 (Reuters) - U.S. FDA:

* FDA ADVANCES POLICIES TO BRING GREATER PREDICTABILITY AND CERTAINTY TO THE DRUG DEVELOPMENT PROCESS

* U.S. FDA SAYS GUIDANCE ISSUED PROVIDES DETAILED OVERVIEW OF THE SPECIAL PROTOCOL ASSESSMENT (SPA) PROCESS